St. Jude Medical (St. Paul, Minnesota) could be on the verge of launching its transcatheter aortic valve implantation clinical trial (TAVI) soon. The trial will evaluate the safety and efficacy of the company's transcatheter aortic valve for patients who experience severe aortic stenosis and who may be at an elevated risk for open-heart surgery. (Medical Device Daily)
Read More
